DigitalHealth InvestorTalk Show

What's Next For Telehealth? With Chris Gallagher and Steven Wardell

Steven Wardell — Thu, 24 Sep 2026 15:37:28 GMT

Can telehealth deliver more than just convenience and bust healthcare out of the productivity trap?

Telehealth is no longer just about technology or convenience. It's about supporting every step of care delivery and creating new care models.

In this show we’ll look at:

The current state of the art for telehealth and the way forward
The ongoing hospital budget shock and how this creates a new moment for telehealth
The productivity trap that healthcare has been stuck in for 75 years and the way out

And we'll answer your questions.

Chris Gallagher, MD, is the CEO of Teos Health and former CEO of Access TeleCare, one of the counrty's largest acute care telemedicine providers. He is nationally recognized for pineering virtual care programs including the first virtual cardiac arrest management program.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Boston Health Innovation Night: What's Next In AgeTech? With Kate Brigham and Steven Wardell

Steven Wardell — Fri, 18 Sep 2026 02:26:53 GMT

This event is co-hosted with Boston Health Innovation Night and AgeTech Boston.

Our Guest of Honor, Kate Brigham, founder of AgeTech Boston, will make opening remarks on the theme of "What's Next in AgeTech."

Thur. Sept. 17, 2026 at the Liberty Hotel in Boston (the Panopticon).

DigitalHealth InvestorTalk: The Battle For Mastry Between Software and AI with Harry Glorikian

Steven Wardell — Sun, 13 Sep 2026 16:24:29 GMT

In healthcare, the software that people use is now fighting the AI underneath it for the same prize: the customer, the data, and the future.

The next decade of competitive advantage will be decided by who controls the software layer between people and AI. Most companies haven’t noticed that the fight has started.

This show draws on the argument: when software disappears into intent, advantage shifts to whoever owns the defaults, the memory, and the trust.

For thirty years technology shifts have reshaped who wins. This time, the shift is different. AI agents don’t wait to be asked. They anticipate, orchestrate, and act. When software disappears into intent, the old questions stop mattering. Which app? Which vendor? Which features? Wrong questions. The real question is who owns the defaults, the memory, and the trust.

In this show we’ll look at:

The healthcare data arenas like EMR data, clinical trial data, and patient reported data
The strategies of the AI hyperscalers versus the human-facing software layer
How this struggle will play out, who wins, and who loses.

And we’ll take your questions.

Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, where his work focuses on how AI rewrites competitive strategy and governance for lasting advantage. For more than three decades he has built, invested in, and advised companies at the convergence of healthcare, life sciences, and data-driven technology. His new book, The Invisible Interface: How AI Turns Intentions into Actions - and Who Wins (foreword by Don Norman), maps exactly this fight.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

A new birth of consumerism? With Steven Wardell, Jarred Bressner, and Todd Pietri

Steven Wardell — Thu, 18 Jul 2024 17:49:42 GMT

Consumers are increasingly spending their own dollars and becoming the decision makers in healthcare

In the show we’ll dive into:

New technologies like telehealth and smartphones have created a supply shock of healthcare options for consumers
New products and business models are gaining traction
But will consumer behavior change fast enough and will consumers really pay?

Todd Pietri and Jarred Bressner are partners at Activate Venture Partners.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

DigitalHealth InvestorTalk: Training AI Search Engines To Recommend You

Steven Wardell — Tue, 28 Jul 2026 18:59:55 GMT

Marketing is about meeting customers' needs. But how do we do this with a changing landscape and what if the customer is an AI agent?

The marketing landscape is changing dramatically. Customers may go to an AI chatbot for answers instead of a search engine, obseleting SEO and ads from vendors in one shot. And what if the customer you're really selling to is an AI agent?

In this show we’ll look at:

- What are modern AI SEO, AI search, and AI marketing?

- How do you get your product into a chatbot's answer?

- How do you get chosen by AI agents?

And we’ll take your questions.

Dale Bertrand is an SEO strategist and founder & CEO of Fire&Spark agency.

Noah Goldfarb is the founder of the Digital Health Growth Mastermind and a director at Fire& Spark agency.

Who are the Digital Health Consolidators?

Steven Wardell — Fri, 06 Dec 2024 15:59:34 GMT

Digital health sectors are maturing and consolidators are circling. Have some recent acquisitions kicked off the game of musical chairs?

In the show we’ll dive into:

- There has been tremendous entry of innovators into healthcare since 2009 but consolidation has typically been weak

- Some recent acquisitions like Virgin Pulse & HealthComp and Veradigm's acquisition of ScienceIO show that the pace is picking up

- We look at the different subsectors of digital health, the consolidators in each subsector, and the potential for big tech and other outsiders to pounce

And we'll answer your questions

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

From GenAI to Patient Agency with David Shaywitz and Steven Wardell

Steven Wardell — Fri, 13 Mar 2026 01:30:06 GMT

The amount of healthcare data keeps growing. The tools we have keep improving, including new GenAI tools.

But to truly drive better healthcare outcomes, we need to improve the agency of both patients in healthcare systems and of consumers at home.

In this show we'll cover:

- The new landscape of data and tools in healthcare

- Extracting meaningful insight for care delivery

- Using GenAI and digital tools to drive behavior change and improved health

And we'll answer your questions.

David Shaywitz, MD, PhD, is Chief Medical Scientist at Lore Health.

What's Working in Digital Health with Steven Wardell and Alex Lennox-Miller

Steven Wardell — Thu, 23 May 2024 13:25:44 GMT

After an unprecedented wave of software innovation, where are digital health products creating clinical and financial value for buyers?

In the show we’ll dive into:

There has been a tremendous amount of software innovation in healthcare since 2009 across all subsectors
But the digital health sector frequently suffers from weak product adoption
We look at those markets in healthcare where digital health products are working to deliver clinical and financial value to buyers
We also look at the latest fundraising trends

Alexander Lennox-Miller is a healthcare IT analyst at CB Insights where covers how emerging technologies are changing front desk and back office workflows in healthcare. You can follow him on LinkedIn.

Find future shows and events at: StevenWardell.Eventbrite.com.

Where Can Healthcare Best Use AI? With Steve Wardell and Chad Pytel

Steven Wardell — Mon, 10 Feb 2025 21:31:09 GMT

What are the new capabilities of modern AI and where can they be best used in healthcare to solve problems?

There's been a flurry of healthcare AI startups since the arrivel of ChatGPT, and the sector is white hot with investors. What are the problem areas in healthcare that are amenible to the capabilities of generative AI?

In this show we'll cover:

- The capabilities of generative AI

- The problem areas where AI can help and where startups are buidling products

- The obstacles like keeping personal healthcare data private

And we'll answer your questions.

Chad Pytel is the founder and CEO of thoughtbot, which helps companies with strategy, design, product management, and development.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm, and the author of The Future of Digital Health. Follow him on X.com/StevenWardell.

Key Longevity Insights You Need To Know with Soheil Saadat and Steven Wardell

Steven Wardell — Thu, 16 Oct 2025 00:14:59 GMT

Longevity care is making advances and growing more popular among consumers. What is a framework to start extending your healthspan?

Longevity isn’t just about adding years to life, it’s about adding life to those years. What steps can you take today to extend your healthspan and enhance your quality of life? What framework can help you identify major risks and set yourself up for long-term vitality?

In this show we'll cover:

- A practical framework for extending your healthspan

- The major health risks and how to prevent problems starting early

- The latest advances in longevity science

And we'll answer your questions.

Dr. Soheil Saadat is the founder and CEO of GenieMD, a San Francisco Bay Area–based telemedicine and digital health company that has treated millions of patients worldwide. GenieMD focuses on virtual care that promotes vitality and longevity, AI-driven chronic disease management, and advanced healthcare communication technologies. Elora Health, a part of GenieMD, is dedicated to longevity, prevention, and healthspan optimization.

Why So Few Good Exits in Digital Health? With Steven Wardell and Steve Rubis

Steven Wardell — Sat, 07 Jun 2025 12:06:33 GMT

Looking at the business models and trends in digital health, few have led to successful exits. We look in to what it means for the future.

Electronic medical records, revenue cycle management, telehealth, digital care management, virtual clinics, clinical decision support tools, employer health benefits, clinical trial automation software, drug discovery software. There have been few successful exits in digital health. We look at why.

In this show we'll cover:

Specific cases like Teladoc, Livongo, 23andMe, Epic, and more.
SPACs and Chinese reverse mergers
The structure of the industry and what it means for the future

And we'll answer your questions.

Steve Rubis is Chief of Staff at Access TeleCare, a telehealth company, and he was formerly a digital health equity research analyst on Wall Street . You can follow him on LinkedIn.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health. You can follow him at X.com/StevenWardell

How New Tech Is Transforming Care with Steven Wardell and Tomer Bentzion

Steven Wardell — Wed, 04 Sep 2024 23:08:07 GMT

New tech is capturing more kinds of data, more continuous data, and data in new care settings that is transforming how we provide care.

In the show we’ll dive into:

How new technologies are offering a better understanding of disease - more data, more continuous data, and clinical data in more local settings.
How better data is offering opportunities to improve care delivery.
How rigidities like regulations and payment models are are slowing down more effective care.

And we'll answer your questions

Tomer Bentzion is the founder and CEO of LiveMetric, the first FDA-cleared wrist-based continuous blood pressure monitoring solution, and a serial entrepreneur.

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow him for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Providers Are Winning Digital Health with Steven Wardell and Adam Kaufman

Steven Wardell — Fri, 16 Aug 2024 22:50:16 GMT

Who stands to eat the most wedges of cheese from the digital health wheel? Payers, Patients, Pharma, software vendors, Providers?

In the show we’ll dive into:

- The digital health category is maturing as technology stops being shocking and becomes mundane

- Competition heats up and differentiation fades; the different actors jocky for position

- Who will win the digital health market and be the big cheese?

And we'll answer your questions

Adam Kaufman is the publisher of BearingOn.Health and an adjunct professor of economics at USC. Follow him at: https://www.linkedin.com/in/adkaufman/.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

A Solution for High Healthcare Costs with Matthew Holt and Steven Wardell

Steven Wardell — Tue, 15 Oct 2024 14:07:52 GMT

Americans spend more than anyone on their healthcare. There are only 4 ways to get costs down but breakthroughs are tough.

In the show we’ll dive into:

- The only way to cut heatlhcare costs are cut prices, cut use, reduce unnecessary services, and replace higher cost services with lower priced ones

- We look at each way to cut costs with policy innovation promising to reduce unnecessary services and tech innovation promising to introduce lower cost services

- But each move in healthcare is opposed by entrenched interests; who is budging first?

And we'll answer your questions

Matthew Holt is the President of SMACK Consulting and a healthcare curmudgeon. He is best known as the founder of Health 2.0 and The Health Care Blog (https://thehealthcareblog.com/).

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

How Tech Empowers Aging Boomers with Meredith Oppenheim and Steven Wardell

Steven Wardell — Fri, 07 Nov 2025 21:58:20 GMT

From Crisis to Catalyst - the Silver Tsunami poses a resource crisis for society. But can tech help us meet the challenge?

The Silver Tsunami will strain the healthcare system and be taxing for workers. But could new tech help seniors remain active and productive while reducing the strain on the system?

In this show we'll cover:

- How to think about approaching seniors as a market with new solutions

- New enabling technologies

- Novel ways that tech keeps seniors active

- Ways tech can cut retirement costs

And we'll answer your questions.

Meredith Oppenheim is an expert on aging and the founder of the Vitality Society. You can follow her on LinkedIn. With over three decades serving seniors and asset managing multi-billion-dollar senior housing portfolios for leading owners and operators, Meredith Oppenheim is a nationally recognized thought leader whose work has been featured in The New York Times, The Wall Street Journal, and ABC News. She is a frequent guest speaker for universities, hospitals, and companies, helping to shape the future of aging with vitality.

What's Working in Digital Health with Steven Wardell and Amrit Panjabi

Steven Wardell — Fri, 23 May 2025 23:32:18 GMT

The Digital Health sector is driving into new opportunities along with technology and economic shocks. We take a look at what's working.

The digital health sector is uncovering new opportunities for technology in healthcare and new business models while being roiled by technological and economic shocks. Meanwhile there is a cloud over the industry - why so few big tech winners and successful exits?

In this show we'll cover:

What products are working in the marketplace?
What new technologies, products, and business models are appearing?
What do the economic shocks mean for young companies?
When will we see more successful exits?

And we'll answer your questions.

Amrit Panjabi is the Digital Health analyst at CB Insights and a venture capital fellow at Alumni Ventures. You can follow him on LinkedIn.

GenAI is not the endgame in Digital Health with Lisa Suennen and Steven Wardell

Steven Wardell — Sun, 14 Sep 2025 17:12:39 GMT

You need more than GenAI. Entrepreneurs need to keep the focus on solving the buyers' biggest pain points.

GenAI is the hottest buzzword in healthcare, and it seems almost necessary to be a "GenAI Native" company in order to win VC funding today.

As founders debate whether to have a proprietary LLM and where how to have a moat in the age of GenAI, it's important not to lose sight of the most basic ingredient for an innovative product: to solve a major pain point for the buyer using whichever technology approach you use.

In this show we'll cover:

- While GenAI is all the rage, you need more than just AI

- How to know you're solving the buyer's biggest problems and how to build a moat

- Are services companies dead? Where do medical devices and disgnostics fit in?

- What to do when clinical buyers don't even want GenAI

And we'll answer your questions.

Lisa Suennen is a partner at AHA Ventures, the fund of the American Heart Association, and she's the Venture Valkyrie. Follow her at: https://www.linkedin.com/in/lisasuennen/

Consolidation in Employer HealthTech with Chris Michalak and Steven Wardell

Steven Wardell — Fri, 27 Mar 2026 12:14:44 GMT

There's been massive innovation and entry into the Employer HealthTech sector and now consolidation is playing out. The endgame is near.

The right combination of health benefits provided by employers can attract and retain talent, build company identity and morale, promote better health and productivity among employees, and bend the medical cost trend downward over time. So for over 20 years employers have been picking and providing innovative mixes of healthcare and programmatic health benefits to employees to earn these advantages. And the market has responded with massive entry of new products, talent, companies, and investment capital.

Now we're seeing emergent winners and losers, changing buyer preferences, maturity of the sector, aggregation of services, and the uptick of consolidation in the industry.

In this show we'll cover:

- The story of the employer healthtech thus far

- Market maturation, changing buyer preferences

- The uptick in consolidaiton and what's next

And we'll answer your questions.

Chris Michalak is the Executive Chairman and former CEO of Personify Health, the leading provider of navigation, wellness, and care management solutions to employers, and he is the former CEO of Buck Consultants.

The Good, The Bad, and The Ugly of AI with Steven Wardell and Ron Razmi, MD

Steven Wardell — Thu, 11 Apr 2024 02:53:39 GMT

In the show we’ll dive into:

The AI products and business models in healthcare that will be successful
The limitations and problems of AI especially in a healthcare context
The barriers to adoption that AI faces

Ron Razmi, MD, is a cardiologist and venture partner at Zoi Capital and the former CEO of Acupera. He is the author of the book AI Doctor: The Rise of Artificial Intelligence in Healthcare. You can follow him on LinkedIn at linkedin.com/in/ronald-m-razmi-md-2b55b8.

Should You Avoid Being a Medical Device? With Steven Wardell and Joe Schwendt

Steven Wardell — Tue, 02 Dec 2025 01:07:49 GMT

What's the line for being classified as a medical device? Is it worth it today to be a medical device? What is going on in medtech?

What's the line for being classified as a Medical Device? Is it worth it today to be a medical device? What is going on in medtech? The promise of Medical Devices used to be that it wasn't that hard to provide great clinical value for an unmet medical need with a new device and with an straightforward FDA process you could have a high-growth, high-margin product. But what is the real opportunity today?

In this show we'll cover:

What are the challenges facing Medical Devices today?
What are the tradeoffs to avoiding or choosing the medical device pathway?
What is the real cost difference?
How does AI come into play?

And we'll answer your questions.

Joe Schwendt is the Founder and CEO of Runway Hero, a boutique consultancy that helps MedTech and Pharma teams build modern medical device software fast, compliant, and inspection-ready. With three decades in regulated digital products, he turns concepts into validated releases with clean documentation, disciplined engineering, and clear business outcomes.

A Tech Framework for Aging In Place with Steven Wardell and Neal Shah

Steven Wardell — Thu, 23 Jan 2025 17:27:07 GMT

Tech can help the Silver Tsunami age in place. Here's a framework for what is needed at each level of care.

Aging is the biggest demographic trend in the US and the world. There isn't enough skilled care available so tech will fill the gap.

Seniors want to age in place, and there is a greater opportunity than ever to meet the needs of aging seniors in-home with technology.

In this show we'll cover:

- What are the needs of seniors as they age

- What are the different levels of care that seniors need and go through

- Where can tech play a role in helping seniors age in place

And we'll answer your questions.

Neal Shah is the CEO of CareYaya and America's Chief Elder Officer. You can follow him at: X.com/NealKShah

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health. Follow uim at X.com/StevenWardell.

Now We Need To Win 'The Scale Game' with Steven Wardell, Alyssa Jaffee, and Chrissy Farr

Steven Wardell — Fri, 09 May 2025 20:22:04 GMT

Healthcare incumbents are bigger than ever. To matter to them and to sell to them, digital health companies need to scale up.

The competitive marketplace is changing and healthcare incumbents -- like providers, payers, and pharma -- are bigger than ever. In order to be relevant and sell into the incumbents, digital health vendors need to solve bigger problems than ever before. And many will need to scale up through acquisitions.

In this show we'll cover:

- The changing marketplace for healthcare solutions . . . and the supersized incumbents and solution buyers

- How digital-health software companies need to respond

- What it will take for digital health companies to scale up to meet the challenge

And we'll answer your questions.

Chrissy Farr is a founder of Scrub Capital, an early-stage venture fund, and the CEO of Second Opinion Media.

Alyssa Jaffee is a partner at 7wire Ventures, serving in board roles at NOCD, Summer Health, Zerigo Health, Jasper Health, MedArrive, and Brightline.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health.

What's Happening at ViVE in February? With Adam Kaufman and Steven Wardell

Steven Wardell — Sat, 14 Feb 2026 01:41:27 GMT

We look at what to expect from the ViVE Conference in Los Angeles in February, including innovations and investor sentiments

Adam and I offer a preview of the state of digital-health fundraising, enterprise budgets, and innovation that we'll see at the ViVE conference covering payers and providers.

Will the barbell fundraising environment continue? What will be the favored investment themes? Are rollups picking up steam? When will the great shakeout arrive? What will happen to the Zombiecorns?

In this show we'll cover:

What to do now to prepare for the ViVE Conference in February
How to get the most out of your time and out of meetings
Views on the future of the fundraising, consolidation, and IPO environments for digital health in 2026

And we'll answer your questions.

Adam Kaufman is the publisher of BearingOn.Health, an advisor to health systems, pharma companies, and innovative digital health companies, and an adjunct professor of economics at USC. Follow him at: https://www.linkedin.com/in/adkaufman/.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

The Return of the Digital Health Solution Aggregators with Steven Wardell and Michael Pace

Steven Wardell — Mon, 10 Jun 2024 16:53:46 GMT

In the show we dive into:

What are the hubs of digital health benefits solutions -- like wellness, navigation, care management, and more
What do the point solutions do in response to the emergence of these marketplaces?
What are the Solution Aggregators doing next, and what should we know about Accolade, Quantum, Collective, Solera, Vera Whole Health, and Virgin Pulse?
And we'll answer your questions

Michael Pace is the CEO of PalmHealthCo, a healthtech commercialization consulting firm and he is the former head of Market Access at Pear Therapeutics. You can follow him at https://www.linkedin.com/in/michaelpace-dtx/.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Building a Health Innovation City with Steven Wardell and Niklas Anzinger

Steven Wardell — Thu, 31 Oct 2024 17:00:48 GMT

Why we need a new city for our biggest innovations, what a health innovation city should include, and how it's going in Vitalia

In the show we’ll dive into:

- What it takes to build a new health innovation city and how this new foundation will enable fast clinical trials, patient right-to-try, and much more

- What's going on at Vitalia City (vitalia.city) and what is the agenda for their "pop-up city" in Jan.-Mar. 2025 in Honduras.

- What are some of their recent achievents in implants, longevity, and plasmid gene therapy

And we'll answer your questions

Niklas Anzinger, founder & CEO of Vitalia the health innovation city in Roatan, Honduras.

How Employers Are Advancing Mental Health witih Steven Wardell, Jarred Bressner, and Pierce Crowley

Steven Wardell — Mon, 03 Mar 2025 22:53:32 GMT

Americans face a mental health crisis made worse by COVID stress and lockdowns. Will tech ride to the rescue of employers?

The mental health crisis has never been greater with growing demand, strained care resources, and a growing problem of junk care -- and employers are looking for answers.

In this show we'll cover:

The crisis of supply and demand for mental health care
Novel solutions for employers enabled by tech
What's working now and what does the future hold

And we'll answer your questions.

Jarred Bressner, MD, is a principal at Activate Venture Partners.

Pierce Crowley is an associate at Activate Venture Partners.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health.

Can we live long enough to live forever? With Steven Wardell and Gil Blander

Steven Wardell — Sat, 03 Aug 2024 15:16:59 GMT

Optimal fitness and longevity are an increasingly realistic goal, a lifestyle, and a business opportunity. We discuss.

In the show we’ll dive into:

Is it possible to achieve optimal fitness as we age? What kind of longevity will be possible in the future?
How do we monitor ourselves and maintain a healthy lifestyle? What are some goals for optimal wellness?
What are the markets and business opportunities for optimal fitness and longevity?

And we'll answer your questions

Gil Blander is the Founder and CSO of InsideTracker, an optimal fitness and nutrition company. He is internationally recognized for his research in the basic biology of aging and translating research discoveries into new ways of detecting and preventing age-related conditions. You can follow him at X.com/GBlander1

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

DigitalHealth InvestorTalk: Will GenAI Win This Time? With Steven Wardell and Marco Smit

Steven Wardell — Fri, 20 Jun 2025 18:33:07 GMT

GenAI business models in healthcare look different than the digital health revolution of 2009, which was about SaaS and workflow automation.

GenAI business models are about intelligently converting free data into structured fields, making decisions, and taking action, which puts them ahead of older digital health models of simple workflow automation powered by software licensing and SaaS business models. Will that be enough to create winner GenAI companies where the last generation failed?

In this show we'll cover:

Looking at reasons old digital health business models failed
How GenAI is different and why Gen AI companies have advantages compared to incumbents now
Where does Agentic AI fit in?
How AI regulation will shape what's possible in healthcare
How do digital health companies succeed in this challenging environment?

And we'll answer your questions.

Marco Smit is the head of business development at Gesund.ai, which helps AI teams become ready for the FDA. You can follow him on LinkedIn.

What adds sizzle to a fundraise or acquisition?

Steven Wardell — Mon, 01 Jul 2024 02:02:37 GMT

Not all digital health companies and strategic transactions are equal. Some have more sizzle and get more attention.

In the show we’ll dive into:

How does the fundraising and acquisition market look and where is it headed?
What is the steak and the sizzle that wins attention for young digital health companies?
How do company leaders position themselves now to get ahead?

And we'll answer your questions

AJ Loiacono is the CEO of Capital Rx, which provides enterprises with a platform to manage their pharmacy benefits. Follow him at https://www.linkedin.com/in/capitalrx/.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts

What Will Happen to Employer HealthTech? With Steven Wardell and Marcus Osborne

Steven Wardell — Fri, 10 Jan 2025 00:53:40 GMT

In the show we’ll dive into:

- How the employer healthtech sector is evolving

- Trends at employer benefit leaders and their changing buying preferences

- Signs that a consolidation wave is building

And we'll answer your questions

Marcus Osborne is the executive chairman of Rightmove Health, a virtual movement health company. He is a former SVP of Walmert Health. You can follow him on X.

Fundraising With Crowd Challenges and Competitions

Steven Wardell — Wed, 20 Aug 2025 17:32:13 GMT

As digital health retrenches and AI explodes, what are creative ways for entrepreneurs to raise money?

Digital health fundraising is tough as business uncertainty grows and VCs retrench. But buoyed by positive regulatory shifts and new technologies, crowdfunding and competitions are emerging as a new way for innovators to win visibility, validation, and funding for their companies.

In this show we'll cover:

1. What's the state of the fundraising environment for young digital health companies

2. How has the environment for crowdfunding and competitions evolved?

3. What are some differences and benefits of crowdfunding

And we'll answer your questions.

Alex Fair is the Managing Partner of MedStartr Ventures

The Healthcare AI Arms Race with Fawad Butt and Steven Wardell

Steven Wardell — Mon, 13 Oct 2025 23:05:36 GMT

Payers and Providers are looking for greater efficiency using GenAI. But what happens when they unleash the latest AI tools on each other?

There are many opportunities in the healthcare system for GenAI to make contributions in billing, coding, medical records, and administrative. But what happens when providers use the latest in AI to supercharge billing to payers and payers arm up to manage and mitigate and deny?

In this show we'll cover:

- The problems of inefficienty in administrative processes in healthcare

- Opportunities for GenAI at payers and providers in administrative and clinical

- The new arms race over billing between payers and providers

And we'll answer your questions.

Fawad Butt is the co-founder and CEO of Penguin Ai, a GenAI product company that is optimizing the healthcare back office for payers and providers. He is the former Chief Data Officer of Kaiser Permanente. Follow him on LinkedIn.

Investor Themes for a New Era with Amir Lubin and Steven Wardell

Steven Wardell — Fri, 28 Mar 2025 16:29:26 GMT

Where are the new pain points in the healthcare sector, and what are the new themes that investors are betting on?

In the show we’ll dive into:

- What has the "regime change" of higher interest rates meant for the healthcare system and the innovators who sell into it?

- What are the pain points and themes in healthcare that innovators can address?

- What are the favored technologies and products for the new era?

And we'll answer your questions

Amir Dan Rubin is the founding partner of Healthier Capital, a venture fund. He is the former CEO of One Medical.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

The Consolidation Wave Is Coming

Steven Wardell — Thu, 14 Nov 2024 18:22:14 GMT

We've lived through an unprecedented period of new digital health products and companies. Consolidation follows.

In the show we’ll dive into:

- There has been tremendous entry of new products and companies into all the subsectors of digital health since 2009 but sector consolidation has been consistently weak

- As the sector matures, we're seeing product buyers move toward the enterprise buy and suite-level functionality, driving new consolidation activity

- Will we see a seller's market for digital health companies or a buyer's market

And we'll answer your questions

Ari Tulla is the Founder and CEO of Elo Health, an AI personalization engine delivering the exact nutrients to live better. And he is an investor in byFounders Collective, an early-stage venture fund. You can follow him on X.com/Umbar.

What's Happening at JP Morgan This January?

Steven Wardell — Tue, 16 Dec 2025 02:39:10 GMT

The JP Morgan Healthcare Investor Conference in San Francisco each January sets the fundraising tone for the year - we preview happenings!

As we head into the new year and the great gathering of healthcare investors in San Francisco in January at and around the JP Morgan Healthcare Conference, Adam and I offer a preview of the state of digital health fundraising. Will the barbell fundraising environment continue? What will be the favored investment themes? Are rollups picking up steam? When will the great shakeout arrive? What will happen to the Zombiecorns?

In this show we'll cover:

What to do now to prepare for the JPM Conference in January
How to get the most out of your time and out of meetings
Views on the future of the fundraising, consolidation, and IPO environments for digital health for 2026

And we'll answer your questions.

The Consumer Home Healthcare Revolution with Shilpi Gupta and Steven Wardell

Steven Wardell — Mon, 24 Aug 2026 14:46:05 GMT

Hormones, Biomarkers, and the End of Annual Lab Work: Empowered consumers monitor hormone levels & more from home to optimize their health.

Health tracking used to mean episodic visits to the clinician, followed by tests to rule out what could be wrong. But today, a growing range of at-home monitoring tools, more convenient and affordable than ever, lets consumers track their hormone levels and other key biomarkers continuously, moving from ruling out illness to actively optimizing their health and vitality.

In this show we’ll look at:

The new paradigm of consumer home testing and empowerment and what is enabling it.
Tests that are becoming more available and how they can support your health and wellness
A deep dive on hormones including hormone monitoring, hormone replacement therapy, and options for perimenopausal women.
Why hormones are the missing data layer in longevity, and what continuous monitoring could reveal that annual lab work cannot.

Shilpi Gupta is the founder and CEO of Qyn Labs, a hormone-health company developing at-home, real-time hormone monitoring with a focus on helping women navigate transitions like perimenopause. Before founding Qyn, she helped scale Roomba from a $100M to a $1B business at iRobot and led robotics product development at Amazon.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

The Future of Digital Therapeutics with Eddie Martucci and Steven Wardell

Steven Wardell — Tue, 28 Apr 2026 01:44:49 GMT

Digital is a high-potential modality in therapeutics but 10 years later there are few hit products. What can we expect next?

In this show we'll cover:

Successes and challenges of Prescription Digital Therapeutics 1.0
Will PDTs achieve parity with molecular therapeutics?
What are the current enablers and blockers of better care through digital therapeutics?

And we'll answer your questions.

Eddie Martucci, PhD, is the CEO of Alterris Oncology, a cancer biotech company; Advisor and President (US) of ResilienceCare, a digital health company in oncology care; and was the founding CEO of Akili Interactive, the leading prescription digital therapeutics company. Eddie also serves as a venture advisor to Sofinnova Partners, is on the Program Advisory Board of the MD Anderson Cancer Center's Cancer Neuroscience Program, and advises select founder-led early-stage innovative startup companies through his consulting firm, Martucci Innovations. Eddie has been named a Business Insider 30 Under 40 in Healthcare, and in 2021 was featured as one of Newsweek's "America's 50 Greatest Disruptors."

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

DigitalHealth InvestorTalk: Strategic Alternatives for Zombicorns

Steven Wardell — Thu, 29 Jan 2026 03:00:53 GMT

What's next for funded companies with growth issues?

After the euphoria of the Zero Interest Rate Period (ZIRP) when many companies received significant funding at high valuations, reality has set in for many of those companies. Slower than expected growth, missed milestones, and a more selective funding environment are forcing tough choices on the management teams of these companies.

In this show we'll cover:

The changing opportunities and challenges for digital health companies
The investors' perspectives
The range of strategic alternatives available to companies

And we'll answer your questions.

Ron Razmi, MD, is the Managing Director of Zoi, a health AI advisory and investment firm, and the author of AI Doctor: The Rise of Artificial Intelligence in Healthcare. A cardiologist by training, he was previously a McKinsey consultant and CEO of health technology company. He currently writes a column for Fast Company and the The AI Doctor Blog on substack, and comments regularly on CNBC, Fox Business, and other media outlets on the health economy.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

GenAI Is Revolutionizing Pharmacy with Harry Travis and Steven Wardell

Steven Wardell — Mon, 08 Dec 2025 23:10:49 GMT

Pharmacy was based on pills, and PBMs were based on margins. GenAI challenges both.

The practice and business of pharmacy is one of the most, if not the most, data intense medical professions and therefore is more susceptible to disruptive AI than any other healthcare profession.

In this show we'll cover:

How AI is freeing pharmacy operation teams from the tyranny of the screens.
There are dozens of early-stage companies powered by AI tools that are working to automate or optimize every step in the process of filling a prescription and determining the appropriate insurance coverage.
Over $1 billion dollars in capital has been invested in this space over the past three years.
Drug companies are launching Direct to Consumer websites for their patented medicines. How do these work and will they provide better access for patients?
Will Most Favored Nations pricing have an effect on drug prices

And we'll answer your questions.

Harry Travis is the President of The Travis Group. He provides strategic consulting and executive coaching services to both US-based and international clients in the pharmacy, digital medicine, and medical technology markets. He is also the founder of TheRxRoundtable.com, which is a network of expert advisors to the pharmacy and pharmacy technology space. Prior to founding The Travis Group, he was Senior Vice President, Member Services Operations at CVS Caremark. Harry also held senior leadership positions with Baxter Healthcare, Cardinal Health, Accredo/Medco, and Aetna, where he served as the VP of Aetna’s Specialty and Home-Delivery Pharmacy business.

The Role of AI in Genomics for Optimal Health

Steven Wardell — Fri, 26 Jul 2024 14:01:33 GMT

In the show we’ll dive into:

How AI adds to reading and interpreting genomic information from blood or biopsy
Pros & cons of “black box” vs “explainable white box” AI algorithms
Where the opportunities are to diagnose and manage disease better
What is holding us back from curing inflammatory & autoimmune diseases today?

And we'll answer your questions

Amrie Grammer, PhD is the Co-Founder and President of Ampel BioSolutions, a precision medicine company that uses RNA analytics and predictive AI to manage disease. Follow her at: https://www.linkedin.com/in/amrie-grammer-phd-1351551b/

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

What Next-Gen MedTech Brings to Longevity with Lana Caron and Steven Wardell

Steven Wardell — Mon, 12 Jan 2026 12:55:31 GMT

Building on advances in technology, MedTech is increasingly able to solve health problems and give us more changes for a long life. From spotting health emergencies earlier to replacing failing organs, the investment potential for the sector is growing.

In this show we'll cover:

- New technologies enabling medtech

- Surprising new capabilities in heatlhcare

- The ways that medtech will solve aging

And we'll answer your questions.

Lana Caron Lana Caron is a medtech and digital health veteran on a mission to make aging optional and longevity mandatory. As a General Partner at Solas BioVentures, she invests in medtech and biopharma innovations poised to transform how long and how well we live. Previously, she led digital health and AI investments at Philips Ventures and held leadership roles at medtech companies innovating to improve our lives.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

DigitalHealth InvestorTalk: The new patient journey in the age of AI with Sage Khanuja and Steven Wardell

Steven Wardell — Thu, 27 Aug 2026 21:16:58 GMT

Pharmaceutical manufacturers spend more than $40B annually on advertising and promotion, patient services, and Hubs. Only about 3% of Americans are even aware they offer resources like co-pay assistance and patient support programs. Little surprise then that between 20% to 30% of prescriptions are never filled.

Emerging AI-powered advocates are now available 24/7 to patients and healthcare providers via the phone, SMS, and web, significantly reducing friction and streamlining the path to therapy. Imagine patient journeys orchestrated by personal concerges that can

Answer any medication-related question
Verify insurance benefits, both Rx and medical
Find and schedule doctor appointments
Track down prior authorizations
Autonomously enroll patients in affordability programs

That doesn't just translate into higher levels of engagement, but it also results in higher levels of medication compliance and suppports better condition management through longer-term adherence. And it's producing more informed patients -- another step toward healthcare consumerism.

The patient journey is often frustrating to patients who have difficulties using benefits and staying on therapy. AI changes that.

In this show we'll look at the new age promised by AI, when a patient concierge becomes smart and often free:

Navigating the patient to the right benefits
Getting the patient on the right therapy and keeping them adherent
Solving the frictions of the healthcare system.

And we’ll answer your questions.

Sage Khanuja is a Seattle Inno Under 25 honoree as well as the co-founder and President of The RXAssistant (therxassistant.com). Prior to launching the company in 2024, he founded and sold Spira, a no-code telehealth solution, to Galileo.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts: https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify: https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Innovators move to Tech-Enabled Services with Steven Wardell and James Hueston

Steven Wardell — Thu, 24 Apr 2025 01:19:33 GMT

The last decade has seen unprecedented innovation in digital health and agetech but software companies still have trouble selling and there have been few compelling exits. Innovators are now turning to tech-enabled services (TES).

In this show we'll cover:

- What's going on in the innovation economy?

- Why are TES companies attracting attention, winning in the product marketplace, and winning with investors?

- Will AI speed up the move of innovators into TES?

And we'll answer your questions.

James Hueston is an investor at Primetime Partners and a founder of AgeTech NYC. You can follow him on LinkedIn.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the host of the DigitalHealth InvestorTalk Podcast. YOu can follow him on X.com/StevenWardell.

Where is AI working today?

Steven Wardell — Fri, 11 Apr 2025 00:10:34 GMT

AI is reshaping digital health investment and creating winners and losers

In this show we'll cover:

Explore FSI’s latest Report on revenue growth and investment trends across digital health segments
Analyze industry activity in digital health (including Payers, Big Four Tech and Medtech companies)
Deep dive on AI impact across drug discovery, clinical trials and commercialization
Share predictions on which digital health companies are likely to see successful exits in 2025

And we'll answer your questions.

Barbara Kohler is a Partner at Fletcher Spaght, growth strategy consultants in life science and digital health.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health.

The Revolution in ObesityCare with Sloan Saunders and Steven Wardell

Steven Wardell — Sun, 20 Jul 2025 19:13:41 GMT

New therapies are shaking up the super-category of obssity and diabetes care but it's not enough to just take a drug

DigitalHealth InvestorTalk: How to prepare for your next fundraise with Steven Wardell and Michael Kisch

Steven Wardell — Thu, 25 Apr 2024 16:56:04 GMT

Editor's note: there was an audio problem (low volume) for the first 6 minutes of the show.

In the show we’ll dive into:

- What is going on in the early-stage digital health fundraising market

- How to prepare for your next fundraise and position yourself

- How to figure out which investors add value

Michael Kisch is the managing partner of The Range, a global health tech advisory firm, and a 3-time digital heatlh CEO. Follow him at X.com/SurfSki

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

DigitalHealth InvestorTalk: NextGen ConsumerTech Is Revolutionizing Care with Maheen Adamson and Steven Wardell

Steven Wardell — Fri, 01 Aug 2025 20:51:18 GMT

New capabilites in the consumertech we buy is bringing to our fingertips new sensors, new data, better data, and new forms of care

Therapeutic videogames for kids with ADHD, giving voice to people who have lost the ability to speak, preventing nightmares, predicting heart attacks. . .

Modern consumertech has new sensors and capabilities giving us better data, analysis, prediction, diagnosis, monitoring, and therapeutic options.

In this show we'll cover:

The new tech in consumer devices
Where it is working in care
The regulatory environment
Creative applications of new tech to care

And we'll answer your questions.

Maheen Adamson is a clinical professor at Stanford Neurosurgery and the CEO of Soof Solutions, a neurosolution provider that restores voice to the speechless.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health.

Is the venture model a bust in healthcare? With Steven Wardell and Sam Toole

Steven Wardell — Thu, 09 May 2024 21:16:59 GMT

The boom of digital health venture funding has not produced the returns investors hoped. What's next?

In the show we’ll dive into:

What problems plague the digital health sector: higher costs, slower scaling, longer sales cycles
Are there areas where the venture model works in healthcare software and services?
What are the future opportunities?

Sam Toole is a Partner at Primary Venture Partners, an early-stage venture fund. You can follow him on Twitter @SamDToole

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633
Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ

Go-To-Market Strategies in 2024 with Steven Wardell and Dutch Dwight

Steven Wardell — Fri, 05 Apr 2024 19:49:44 GMT

In the show we’ll dive into:

The changing needs of providers and payers and best ways to sell to them
A fresh take on Go-To-Market Strategy for today's environment
Expert use of sales enablement tools, buyer personas, value propositions, and scripting

And we'll answer your questions

Dutch Dwight is the VP of Business Development at Woebot and is a multi-time head of sales for digital health companies. You can follow him on LinkedIn.

Follow on Eventbrite to hear about new events and live shows: ⁠StevenWardell.EventBrite.com⁠. Subscribe to the podcast.

Here Comes Telehealth 2.0 with Dr. Lyle Berkowitz and Steven Wardell

Steven Wardell — Tue, 07 Apr 2026 18:51:02 GMT

In this show we'll cover:

What telehealth has meant up to now
How patients, clinicians, technology, and care delivery have changed
A new vision of telehealth

And we'll answer your questions.

Lyle Berkowitz, MD, is the founder and Executive Chairman of KeyCare, a network of AI tech-enhanved virtual care providers working on an instance of Epic optimized for telehealth. Follow him on LinkedIn.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

DigitalHealth InvestorTalk: What Digital Health Sectors Are Hot Now? with Adam Kaufman

Steven Wardell — Fri, 20 Dec 2024 01:07:37 GMT

What are the changing priorities of the software budgets of the major healthcare sectors?

The problems facing healthcare incumbents keep changing and so their budget strength and priorities also change. We take a look at the problems and budget strengths today for buying tech by Providers, Payers, Employers, and Pharma.

In this show we'll cover:

- Today's significant problems facing the different sectors of healthcare.

- The strength of healthcare budgets and spendiness on tech.

- Conclusions investors are drawing and where they're putting their chips.

And we'll answer your questions.

Adam Kaufman is the publisher of BearingOn.Health and an adjunct professor of economics at USC. Follow him at: https://www.linkedin.com/in/adkaufman/.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business-development consulting firm, and the author of The Future of Digital Health.

The Future of the Drug Store with Steven Wardell and Harry Travis

Steven Wardell — Thu, 26 Sep 2024 22:43:57 GMT

Consumers have more options than ever, conglomerates are looking for weakness, what will happen to the drug store?

In the show we’ll dive into:

Consumers now have more choice than ever before including telehealth prescription companies like Ro and Hims that can cherry-pick the industry
Amazon is re-inventing pharmacy-by-mail while CVS and Walgreens are bringing primary care clinics on premises
Independent pharmacies are closing at record numbers, turning rural America and inner cities into pharmacy deserts.
A volatile mix of labor unrest in the large chain pharmacies plus robotics and AI is creating an uncertain future for a large portion of the country’s registered pharmacists.

And we'll answer your questions

Harry Travis is the President of Travis Group and a former senior executive at CVS and Aetna.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.